New Delhi, May 06, 2024 (GLOBE NEWSWIRE) -- Astute Analytica states that the global apheresis market was valued at US$ 3,248.3 million in 2023 and is estimated to surpass market valuation of US$ 6,882 ...

Terumo Blood and Cell Technologies presents data on collection efficiency process with Spectra Optia(R) Apheresis System at major conferences Lakewood, Colorado, US, May 25, 2023 – Terumo Blood and ...

In recent years, as many of the diseases for which allogeneic HPC transplantation is indicated are associated with advancing age; this therapy has been increasingly offered to patients in their sixth ...

LAKEWOOD, Colo.--(BUSINESS WIRE)-- Terumo BCT has received clearance for the preparation of plasma held at 1° to 6° C within 8 hours and frozen within 24 hours after phlebotomy (PF24) and plasma held ...

Chicago, Feb. 06, 2026 (GLOBE NEWSWIRE) -- According to recent data from Astute Analytica, the global apheresis market was valued at US$ 3,248.3 million in 2023 and is projected to attain a valuation ...

The global Apheresis Equipment Market is valued at $2.01 million in 2023 and is projected to reach a value of $2.20 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.7% from 2024 ...

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT announced today that the Spectra Optia system mononuclear cell (MNC) collection protocol is now cleared by the U.S. Food and Drug Administration (FDA) and ...

SAN FRANCISCO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading software and analytics company for cell and gene therapies, today announced that it will be expanding its technology ...

Autologous peripheral SCT has largely replaced BMT for the treatment of cancer in both adults and children. Cells are collected by apheresis. The technique has been widely used in France since its ...